Marina Basina, MD, Clinical Associate Professor, Department of Medicine, Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine
Research Description: Dr. Basina is actively involved in the Stanford diabetes research community in multiple ways. Dr. Basina was a co-investigator on NIH-sponsored research study of Safety and Efficacy of Sensor-Augmented Continuous Subcutaneous Insulin Infusion in Patients with Diabetic Gastroparesis. The study was presented at the American Diabetes Association Annual Scientific Meeting in 2016, and manuscript is under review in Diabetes Care. She has served as a PI on an investigator-initiated study on the effect of calorie restriction on the prevention of weight gain and improvement of glycemic control in patients with diabetes treated with Avandia in combination with other oral anti-diabetes agents, sponsored by Glaxo-SmithKline. A manuscript from this study is under review. Dr. Basina has served as the primary investigator of a research study comparing two different insulin regimens for diabetes control and for prevention of hypoglycemia in patients undergoing hemodialysis with diabetes-related End Stage Renal disease, sponsored by Sanofi. Continuous Glucose Monitoring System was used in the study as a primary outcome measure for glycemic control on two insulin regimens. The study is completed and manuscript is currently under the preparation. She has previously collaborated with other SDRC members (McLaughlin, Abbasi) in published studies of insulin resistance, dietary interventions and diabetes-associated cardiovascular disease risk. Dr. Basina will serve as a PI on a multicenter randomized controlled trial comparing two basal insulins (Lantus and Degludec) in individuals with type 2 diabetes sponsored by Novo Nordisk (NN1250-4252 - Site 164). This trial will start in March, 2017. In addition, Dr. Basina is a co-leader with Dr. Justin Annes of Enrichment activities in the SDRC, with a focus on community outreach efforts (detailed in the Enrichment section of this proposal). Finally, Dr. Basina is focused on clinical care of subjects undergoing islet auto-transplantation in programs developing under SDRC members, including Drs. Meyer, Park, Visser, Thakor, Maahs, Kraemer and S.K. Kim.
Selected relevant publications and presentations (Stanford DRC Members in BOLD):
1. Basina M. Gestational Diabetogenesis. J Women’s Health Care 1:e106. doi: 10.4172/2167-0420.1000e106, 2012.
2. Jorge Calles, Mark l. Van Natta, Marina Basina, Kristen G. Hairston, William H. Herman, Kenneth l. Koch, Laura A. Miriel, James Tonascia, NIDDK Gastroparesis Clinical Research Consortium, William l. Hasler, Cleveland, OH, Baltimore, MD, Stanford, CA, Winston- Salem, NC, Ann Arbor, MI Continuous Glucose Monitoring (CGM) Plus Continuous Subcutaneous Insulin Infusion (CSII) Reduces Hypoglycemia in Diabetes (DM) with Gastroparesis (GP): A Multicenter Pilot Study (GLUMIT). Platform presentation, American Diabetes Association Annual Scientific Meeting, 2016
3. Simos, A, Basina M. Use of Continuous Subcutaneous Insulin Infusion Patch Pump in a Blind Patient With Type 1 Diabetes and Major Complications. Case Report. Platform presentation, American Diabetes Association Annual Scientific Meeting, 2016